Navigation Links
Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting
Date:11/8/2007

host a live webcast at 4:30 p.m. EST today to discuss these results.

The live webcast can be accessed at: http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=100445&eventID=1673091 (Due to the length of this URL, it may be necessary to copy and paste this hyperlink into your browser. Remove the space if one exists.)

or via the Nabi Biopharmaceuticals website at http://www.nabi.com.

If you do not have Internet access, the U.S./Canada call-in number is 866-202-4683 and the international call-in number is 617-213-8846. The participant passcode is 65486127. An audio replay will be available for U.S./Canada callers at 888-286-8010 and for international callers at 617-801-6888. The replay passcode is 91953104. An archived version of the webcast will also be available on the Company's website, http://www.nabi.com. Both the audio replay and the archived webcast will be available through November 8, 2007. The press release will be available on the company's website at http://www.nabi.com.

About Nabi Biopharmaceuticals

Nabi Biopharmaceuticals leverages its experience and knowledge in powering the immune system to develop and, in certain areas, market products that target serious medical conditions in the areas of hepatitis and transplants, gram positive bacterial infections and nicotine addiction. We are a vertically integrated company with sales of antibodies and other biologics, including Nabi-HB(R) [Hepatitis B Immune Globulin (Human)], a pipeline of products in various stages of development and a state-of-the-art manufacturing capability. The company operates through two strategic business units: Nabi Biologics and Nabi Pharmaceuticals. Nabi Biologics has responsibility for the company's protein and immunological
'/>"/>

SOURCE Nabi Biopharmaceuticals
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Presentation Time Correction: Keryx Biopharmaceuticals Presents at 12:00pm, ET Tomorrow (Oct. 3) at William Blair & Company Small-Cap Growth Stock Conference
2. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
3. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
4. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
5. HEI, Inc. Announces Sale of RFID Division Assets
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
9. Brooke Franchise Corporation Announces Selected July Results
10. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Kurth Krause, an aerospace engineer,for NASA, was giving ... moon, he,was confident that technology and science could ... was one thing that science couldn,t solve.,His wife ... dialysis machines,would keep her alive for awhile, she ... is 69 and is starting dialysis next month. ...
(Date:12/14/2009)... to scans performed in 2007 , , MONDAY, Dec. 14 ... to far more radiation than previously thought and in doses ... two new studies claim. , Based on the findings, reported ... Internal Medicine , the study authors, joined by Archives ... to limit radiation exposure to patients. , "CT has become ...
(Date:12/14/2009)... Decaf may also offer some protection, study finds, , , ... for people who can,t start their morning without a ... may decrease the risk of developing type 2 diabetes. ... that also found the more coffee you drink, the ... was associated with a 7 percent reduction in the ...
(Date:12/14/2009)... CHAPEL HILL -- Type 2 diabetes and obesity are ... Recently published studies suggested that insulin glargine (a synthetic ... be associated with a higher risk of certain cancers ... However, these studies were unable to control for important ... association. , On the other hand, a large ...
(Date:12/14/2009)... lead to better treatments for asthma, COPD, researchers say ... identified five genetic variants that influence lung function, a ... lung diseases. , The international team of researchers compared ... 2.5 million sites across the human genome in more ... team to the five common genetic variants associated with ...
Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
... Solta Medical, Inc. (Nasdaq: SLTM ), a ... it will release its financial results for the first quarter ... May 5, 2009. The Company will also host a ... 4:30 p.m. Eastern Time (1:30 p.m. Pacific) to discuss the ...
... N.C., April 27 Susan Brady of ... professionals in the nation to become certified by ... nonprofit organization that provides advocacy and education for ... demonstrated in-depth knowledge and expertise on best practices ...
... According to new research reported in the ... casei strain Shirota may ease symptoms of anxiety ... Thirty-nine patients with CFS received daily supplements of ... two months. Compared to the placebo group, ...
... at Telemedicine Conference in Las Vegas, Booth 1206 LAS ... Suisse AG (Fora Care,s Swiss sister company) announced today ... American Telemedicine Association (ATA) conference through April 28 at ... The veteran telemedicine companies are presenting at the ...
... following is being issued by American Stroke Association: , , ... It,s better to find out than miss out. Be aware ... and their side effects. Ask if your home should be modified ... doctor, nurse or therapist to clarify any unanswered questions or to ...
... April 27 Daily exposure to toxins in the ... adhesives, and insecticides, are creating a toxic load on ... and asthma. In light of increased awareness of our ... ) announced today the release of three ...
Other Medicine News:Health News:Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call 2Health News:MedThink Communications Account Director Among First to Receive CMPP Certification in Medical Publications Planning and Development 2Health News:New Study Shows Supplementing With Probiotics May Ease Anxiety 2Health News:Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 2Health News:Fora Care and Fora Care Suisse AG Launch Diabetes Telehealth Solution at ATA 3Health News:15 Tips Caregivers Should Know After a Loved One Has Had a Stroke 2Health News:15 Tips Caregivers Should Know After a Loved One Has Had a Stroke 3Health News:Metametrix Announces New Toxic Effects Profiles to Help Combat Growing Concerns About Toxicity and Health 2
(Date:12/14/2009)... Caliper Life Sciences, Inc. ... tools and services for drug discovery and life ... the sale of Xenogen Biosciences Corporation ("XenBio"), a ... Taconic Farms, Inc. for approximately $11 million. ... Caliper,s acquisition of Xenogen Corporation in 2006. ...
(Date:12/14/2009)... The U.S. Food and Drug Administration (FDA) ... Suspension for the treatment of schizophrenia in adults, ... ) announced today. ZYPREXA RELPREVV, a long-acting intramuscular ... to four weeks. ,, Different from both oral ... allow for stable concentrations of the active drug ...
(Date:12/14/2009)... Inc. (OTC Bulletin Board: OXBT) today announced the expansion ... of Lt. Gen. Ronald R. Blanck, DO, U.S. Army ... Associates, a federal health services consulting firm based in ... now has nine members. ,, Dr. Blanck began his ... battalion surgeon in Vietnam. He retired 32 years later ...
Breaking Medicine Technology:Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 57354 1Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 57354 2Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 57354 3Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 1Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 2Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth Personal Emergency Response and Medical Monitoring Syste 57351 3Hollis Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 14094 1Hollis Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 14094 2Hollis Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price 14094 3
... Cytopia,Limited (ASX: CYT) has commenced dosing patients in the ... its vascular disrupting agent (VDA), CYT997.,These studies will investigate ... with high unmet medical need and poor prognoses., ... cancer and have potential for,"blockbuster" sales in the treatment ...
... Children,s DNA, a Hint of a Mutation,s Ancestral African ... to replicate another group,s discovery of an important gene,associated ... particular,variant in DNA that may be more helpful in ... worldwide. The finding suggests that,the gene variant, identified in ...
Other Medicine Technology:Anti-Cancer Drug CYT997 Update 2Anti-Cancer Drug CYT997 Update 3Anti-Cancer Drug CYT997 Update 4Anti-Cancer Drug CYT997 Update 5Gene Hunters Fine-Tune Marker for Common Obesity Gene 2Gene Hunters Fine-Tune Marker for Common Obesity Gene 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: